HDAC9 and cancer: MPT0G030 (3-[7-amino-1-(4-methoxy-benzenesulfonyl)-2,3-dihydro-1H-indol-5-yl]-N-hydroxy-acrylamide) (Figure 1A) is a novel class I HDAC inhibitor that shows broad-spectrum cytotoxicity against various human cancer cell lines.